Contribution of different pneumococcal virulence factors to experimental meningitis in mice

Susanna Ricci1, Alice Gerlini, Andrea Pammolli

  • 1Department of Medical Biotechnologies, Laboratory of Molecular Microbiology and Biotechnology (LA,M,M,B,), University of Siena and Siena University Hospital, Siena 53100, Italy. susanna.ricci@unisi.it.

BMC Infectious Diseases
|September 25, 2013
PubMed
Abstract

Insights

Pneumococcal surface protein A (PspA) aids Streptococcus pneumoniae in causing meningitis, while the capsule is crucial for disease development. PspC plays a minor role in pneumococcal meningitis pathogenesis.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • Pneumococcal meningitis (PM) is a severe infection with high mortality and neurological complications.
  • Streptococcus pneumoniae virulence factors, including capsule, PspA, and PspC, are implicated in PM pathogenesis.

Purpose of the Study:

  • Investigate the roles of Streptococcus pneumoniae capsule, PspA, and PspC in experimental pneumococcal meningitis.
  • Determine the contribution of these factors to bacterial survival, replication, and host inflammatory responses.

Main Methods:

  • Intracranial challenge of mice with wild-type S. pneumoniae and isogenic mutants lacking PspA, PspC, or the capsule.
  • Assessment of survival, bacterial loads, brain histology, and microglial interactions (phagocytosis, survival).

Main Results:

  • PspA mutant showed increased survival and impaired replication in mice, suggesting a role in pathogenesis.
  • The capsule was essential for inducing inflammation, neuronal damage, and mortality.
  • PspC had a limited impact on PM virulence.
  • PspA mutant exhibited reduced survival in microglia.

Conclusions:

  • PspA contributes to PM pathogenesis, potentially via microglial interaction.
  • The bacterial capsule is critical for inducing meningitis, inflammation, and damage.
  • PspC appears to have a minor role in the disease.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...